Chronic Chagas Disease: Clinical Trials

3 trials for Chronic Chagas Disease, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 terminated, 1 withdrawn. 1 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 21Terminated 1
Phase 31Withdrawn 1

Follow Chronic Chagas Disease: new trials by email Literature Review of Chronic Chagas Disease trials Research Report on Chronic Chagas Disease

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Short Benznidazole Regimen for Chronic Phase Chagas Disease Patients
benznidazole 300 mg daily 8 weeks - Chronic Chagas Disease
Phase 3WithdrawnEvandro Chagas Institute of Clinical Research2025-01-302025-03-13
University-Based Chagas Testing in Salta Province, Argentina
Rapid diagnostic test (RDT) for Trypanosoma cruzi infection. - Chagas Disease, Trypanosoma Cruzi Infection
CompletedMundo Sano Foundation25682024-09-112026-06-23
Atorvastatin on Inflammation and Cardiac Function in Chronic Chagas Disease
40 mg Atorvastatin/day for 120 days P.O., Atorvastatin 80, Placebo - Chronic Chagas Disease
Phase 2TerminatedJuan D. Maya3002021-10-122024-09-19

Narrower conditions

Chagas Disease (3)  ·  Inflammation (1)

Broader conditions

Euglenozoa Infections (3)  ·  Infections (3)  ·  Parasitic Diseases (3)  ·  Protozoan Infections (3)  ·  Trypanosomiasis (3)  ·  Vector Borne Diseases (3)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)

Interventions

Rapid Diagnostic Tests (1)  ·  benzonidazole (1)

Sponsors

Evandro Chagas Institute of Clinical Research (1)  ·  Juan D. Maya (1)  ·  Mundo Sano Foundation (1)

Countries

Argentina (1)  ·  Brazil (1)  ·  Chile (1)

Top investigators

Adriana Echazu, PhD (1)  ·  Juan D. Maya, Ph.D. (1)  ·  Ruben O Cimino, PhD (1)

Results publications

PMID 36638112